To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer

NCT06808412 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Rcctal Cancer

Interventions

DRUG: sintilimab combined with bevacizumab and XELOX

Sponsor

xiaohua li